MedPath

Intervention for the Treatment of Depression in Virtual Reality (FlowVR)

Not Applicable
Conditions
F32
F32.1
F32.2
F32.8
F32.9
F33
F33.1
F33.2
F33.8
F33.9
Registration Number
DRKS00034078
Lead Sponsor
Asklepois Klinikum Harburg Zentrum für seelische Gesundheit Klinik für Psychiatrie, Psychotherapie und Psychosomatik
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
66
Inclusion Criteria

Meeting the criteria for Major Depression, Dysthymia, or Recurrent Depressive Disorder according to DSM-5 verified (M.I.N.I.) with current episode, proficient in German language, providing written consent for study participation and the ability to give informed consent.

Exclusion Criteria

Patients with psychosis (including affective disorder with psychotic features), bipolar disorder, post-traumatic stress disorder, acute suicidality, and substance use disorder (currently not abstinent), as well as (partial) inpatient psychotherapy during the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is the change in mindfulness from T0 to T1 and from T0 to T2 (secondary), which is measured by using the Five Facet Mindfulness Questionnaire (FFMQ-D).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath